PMID: 2126007Nov 1, 1990Paper

Sequential release of antigens from chloroform-treated Staphylococcus epidermidis: application towards a possible vaccine

The Journal of Applied Bacteriology
A AhmadG R Skinner

Abstract

This study describes the properties of two potential Staphylococcus epidermidis vaccines prepared by chloroform treatment of bacteria and release of antigen from these chloroform-treated organisms. Both vaccines were antigenic on testing with homologous hyperimmune serum and induced immune reactivity in immunized rabbits. There was protective efficacy in mice against intraperitoneal challenge by Staph. epidermidis.

References

Feb 1, 1979·Journal of Medical Microbiology·S E McKay, J P Arbuthnott
Aug 1, 1978·Australian Veterinary Journal·D L Watson, C G Lee
Aug 1, 1985·Journal of Medical Microbiology·P M NdumbeR J Levinsky
Nov 1, 1988·Zentralblatt Für Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology·Y Ohshima
Apr 1, 1988·The Journal of Antimicrobial Chemotherapy·C Thornsberry
May 1, 1987·Journal of the American Geriatrics Society·G D Christensen
Apr 1, 1987·American Journal of Infection Control·B H HamoryJ P Hutton
Dec 1, 1984·The Journal of Antimicrobial Chemotherapy·R W LaceyC Lincoln
Dec 1, 1984·Journal of Bacteriology·G F AmesS Kustu
May 1, 1980·Journal of Medical Microbiology·O S Kinsman, J P Arbuthnott

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.